Henry Schein, Inc. (HSIC) SVP Paul Rose Sells 2,126 Shares
Henry Schein, Inc. (NASDAQ:HSIC) SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded up 1.39% during trading on Thursday, hitting $174.83. The stock had a trading volume of 412,154 shares. The company has a market capitalization of $13.82 billion, a P/E ratio of 25.55 and a beta of 1.10. Henry Schein, Inc. has a 1-year low of $146.23 and a 1-year high of $186.99. The firm has a 50-day moving average of $175.51 and a 200 day moving average of $176.27. Shares of Henry Schein are set to split on the morning of Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly issued shares will be distributed to shareholders after the closing bell on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The company had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.64 earnings per share. Equities research analysts predict that Henry Schein, Inc. will post $7.27 earnings per share for the current fiscal year.
HSIC has been the subject of a number of research reports. Piper Jaffray Companies initiated coverage on Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. Jefferies Group LLC reiterated a “hold” rating and set a $177.00 target price on shares of Henry Schein in a report on Friday, July 21st. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Credit Suisse Group reiterated a “hold” rating and set a $160.00 target price on shares of Henry Schein in a report on Thursday, July 13th. Finally, Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company’s stock. Henry Schein presently has a consensus rating of “Hold” and an average target price of $186.50.
Several large investors have recently bought and sold shares of HSIC. SpiderRock Advisors LLC bought a new stake in shares of Henry Schein during the first quarter worth about $102,000. YorkBridge Wealth Partners LLC increased its position in shares of Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after acquiring an additional 28 shares in the last quarter. Sun Life Financial INC increased its position in shares of Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after acquiring an additional 573 shares in the last quarter. Lee Financial Co bought a new stake in shares of Henry Schein during the second quarter worth about $161,000. Finally, Westside Investment Management Inc. bought a new stake in shares of Henry Schein during the first quarter worth about $168,000. 89.11% of the stock is owned by institutional investors.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.